FDA approves St. Jude MRI-compatible neurostim lead; OrbusNeich starts China stent trial

@FierceMedDev: Illumina launches new lab service for HiSeq X sequencing systems. FierceDiagnostics article | Follow @FierceMedDev

@VarunSaxena2: ICYMI: Study finds Philips' ventilator helps reduce hospital readmissions for COPD. Article | Follow @VarunSaxena2

@EmilyWFierce: In 10 years, liquid biopsy test for cancer will be part of routine annual exams, says Guardant Health CEO. More from the WSJ | Follow @EmilyWFierce

> St. Jude Medical ($STJ) nabs FDA approval for its Penta MRI-compatible lead for its Protégé MRI system chronic pain spinal cord stimulation. More

> Stentmaker OrbusNeich has started a randomized, 436-patient China clinical trial for its Combo Dual Therapy Stent to treat patients with de novo stenotic lesions in native coronary arteries. It's designed to compare Combo with the Nano Stent from Lepu Medical Technology. More

> The Indian government is looking for more sterilization options as it continues on an aggressive population control campaign. Story

Biotech News

@FierceBiotech: Bristol-Myers flags an early success for PhIII Opdivo study. Article | Follow @FierceBiotech

@JohnCFierce: Americans want Medicare to negotiate lower drug prices -- (one day it's going to come). More from Reuters | Follow @JohnCFierce

> Tekmira changes its name and shuffles away from Ebola. News

> Agenus bags cancer antibodies in $44M deal. More

> Another Alzheimer's upstart swings for a $150M IPO with a PhIII contender. Article

> Bristol-Myers flags early success for PhIII Opdivo study in kidney cancer. Report

Pharma News

@FiercePharma: We've got a brand new special report today! Top 10 pharma companies in social media. Feature | Follow @FiercePharma

@EricPFierce: ICYMI: Gallant Pharma owner notified in jail by FDA he is disbarred for life from the pharma industry. More from PharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: Baxalta tots up winning hemophilia data as new med beats Advate in late-stage trial. More from FiercePharmaMarketing | Follow @CarlyHFierce

> India expands drug pricing with caps for two antibiotics. Story

> Vast majority of consumers want Medicare to negotiate drug prices. Article

> Sanofi preps for 'profitable' dengue vaccine rollout in 20 countries. Report

Animal Health News

> KC Animal Health Corridor investment forum slated for early September. More

> Aratana charts positive results for canine pain drug, predicts 2016 launch. Report

> PetCure spots booming market for radiosurgery in pets with cancer. Story

> Valeant steps into animal health with $800M acquisition of Egypt's Amoun. Article

> Virbac charts strong sales growth, nabs Big Pharma veteran to oversee quality. Item

Biotech IT News

> FDA turns to Google for help spotting adverse events. Report

> Vermillion raises $18.8M to fund escalation of bioinformatics ambitions. News

> Illumina wraps lab automation and software around HiSeq X to lower barrier to mass sequencing. Article

> Report: Danaher nears $30M buyout of computer-aided imaging business. More

> Arivale sets up with $36M, A-list founders and one eye on the R&D potential of its 'dense data clouds.' Story

Pharma Marketing News

> Does high TV ad rotation give patients the wrong idea about drugs? More

> Opdivo trial stopped early as BMS med tops Afinitor in kidney cancer. Item

> AstraZeneca ponies up for heart-attack patients with new Vida Health app. Report

> VC to pharma: Better get on board with digital health marketing. Story

> Lilly adds new Coco the Type 1 monkey tale to its Disney bookshelf. Article